LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 10.16 | 21.74 | 1038 | 463 | 2.2388 | 1.4006 | MN20160310_N01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 12.13 | 21.74 | 2 | 496 | 0.0040 | -0.4106 | MN20160310_N01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 12.13 | 21.74 | 802 | 496 | 1.6158 | 1.2244 | MN20160310_N01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 12.13 | 21.74 | 102 | 496 | 0.2055 | 0.4085 | MN20160310_N01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 12.13 | 21.74 | 1063 | 496 | 2.1416 | 1.3676 | MN20160310_N01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 14.10 | 21.74 | 1 | 540 | 0.0018 | -0.4852 | MN20160310_N01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 14.10 | 21.74 | 800 | 540 | 1.4789 | 1.1761 | MN20160310_N01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 14.10 | 21.74 | 166 | 540 | 0.3069 | 0.5502 | MN20160310_N01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 14.10 | 21.74 | 1067 | 540 | 1.9725 | 1.3155 | MN20160310_N01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 16.07 | 21.74 | 1 | 597 | 0.0017 | -0.4748 | MN20160310_N01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 16.07 | 21.74 | 787 | 597 | 1.3164 | 1.1183 | MN20160310_N01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 16.07 | 21.74 | 174 | 597 | 0.2910 | 0.5450 | MN20160310_N01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 16.07 | 21.74 | 1088 | 597 | 1.8198 | 1.2668 | MN20160310_N01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 18.04 | 21.74 | 1 | 750 | 0.0013 | -0.4526 | MN20160310_N01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 18.04 | 21.74 | 763 | 750 | 1.0166 | 1.0064 | MN20160310_N01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 18.04 | 21.74 | 422 | 750 | 0.5622 | 0.7869 | MN20160310_N01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 18.04 | 21.74 | 1080 | 750 | 1.4389 | 1.1476 | MN20160310_N01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 20.01 | 21.74 | 1 | 901 | 0.0011 | -0.4361 | MN20160310_N01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 20.01 | 21.74 | 765 | 901 | 0.8482 | 0.9397 | MN20160310_N01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 20.01 | 21.74 | 424 | 901 | 0.4701 | 0.7380 | MN20160310_N01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 20.01 | 21.74 | 1098 | 901 | 1.2174 | 1.0746 | MN20160310_N01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 21.98 | 21.74 | 1 | 1108 | 0.0009 | -0.4189 | MN20160310_N01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 21.98 | 21.74 | 713 | 1108 | 0.6433 | 0.8503 | MN20160310_N01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 21.98 | 21.74 | 658 | 1108 | 0.5937 | 0.8243 | MN20160310_N01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 21.98 | 21.74 | 1091 | 1108 | 0.9843 | 0.9944 | MN20160310_N01 | L09 |